741 results on '"Vedadi, Masoud"'
Search Results
2. Kinetic characterization of human mRNA guanine-N7 methyltransferase
3. Structure-Based Discovery of Inhibitors of the SARS-CoV‑2 Nsp14 N7-Methyltransferase
4. The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition
5. Discovery of Nedd4 auto-ubiquitination inhibitors
6. CACHE (Critical Assessment of Computational Hit-finding Experiments): A public–private partnership benchmarking initiative to enable the development of computational methods for hit-finding
7. Development of selective class I protein arginine methyltransferase inhibitors through fragment-based drug design approach
8. Histone H4K20 monomethylation enables recombinant nucleosome methylation by PRMT1 in vitro
9. Discovery of hit compounds for methyl-lysine reader proteins from a target class DNA-encoded library
10. A NSD3-targeted PROTAC suppresses NSD3 and cMyc oncogenic nodes in cancer cells
11. A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization
12. Development of Peptide Displacement Assays to Screen for Antagonists of DDB1 Interactions
13. Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor
14. Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors
15. Discovery of the SMYD3 Inhibitor BAY-6035 Using Thermal Shift Assay (TSA)-Based High-Throughput Screening
16. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex
17. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19
18. Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complex
19. Crystal structure and activity-based labeling reveal the mechanisms for linkage-specific substrate recognition by deubiquitinase USP9X
20. Chemical Tools for the Gid4 Subunit of the Human E3 Ligase C-terminal to LisH (CTLH) Degradation Complex
21. Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase Inhibitors
22. Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric Inhibitors
23. Development of LM-41 and AF-2112, two flufenamic acid-derived TEAD inhibitors obtained through the replacement of the trifluoromethyl group by aryl rings
24. Discovery of Small-Molecule Antagonists of the H3K9me3 Binding to UHRF1 Tandem Tudor Domain
25. Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3
26. The Cryptosporidium parvum Kinome
27. SETD7 functions as a transcription repressor in prostate cancer via methylating FOXA1
28. Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors
29. Structure-activity relationship studies of G9a-like protein (GLP) inhibitors
30. A Suite of Biochemical Assays for Screening RNA Methyltransferase BCDIN3D
31. Author Correction: Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response
32. Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response
33. Human MettL3–MettL14 complex is a sequence-specific DNA adenine methyltransferase active on single-strand and unpaired DNA in vitro
34. Discovery of a chemical probe for PRDM9
35. A chemical biology toolbox to study protein methyltransferases and epigenetic signaling
36. Development of HC-258, a Covalent Acrylamide TEAD Inhibitor That Reduces Gene Expression and Cell Migration.
37. Probing the mechanism of Cbl-b inhibition by a small-molecule inhibitor
38. SS148 and WZ16 inhibit the activities of nsp10-nsp16 complexes from all seven human pathogenic coronaviruses
39. Supplementary Dataset 2 from WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
40. Supplementary Dataset 1 from WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
41. Supplementary Dataset 5 from WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
42. Supplementary Dataset 4 from WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
43. Data from WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
44. Supplementary Dataset 3 from WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
45. Supplementary Methods-Figures-Tables from WDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in Neuroblastoma
46. Discovery of Nanomolar DCAF1 Small Molecule Ligands
47. PR Domain-containing Protein 7 (PRDM7) Is a Histone 3 Lysine 4 Trimethyltransferase
48. A Radioactivity-Based Assay for Screening Human m6A-RNA Methyltransferase, METTL3-METTL14 Complex, and Demethylase ALKBH5
49. Chemical tools for the Gid4 subunit of the human E3 ligase C-terminal to LisH (CTLH) degradation complexElectronic supplementary information (ESI) available. See DOI: https://doi.org/10.1039/d3md00633f
50. Discovery of selective activators of PRC2 mutant EED-I363M
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.